Tailoring Messages to the U.S. Latinx Community
Code Switch
The president of the Latino Commission on AIDS talks about tailoring messages to U.S. Latinos
by Larry Buhl
In early September in Philadelphia, NMAC (formerly...
UFO Plan Meets IDUs
Finger on the Pulse
The UFO Plan meets young IV drug users where they are
by Larry Buhl
Hepatitis prevention and treatment efforts depend on outreach. For...
Curing Hep B
C2B
The success in curing hep C fuels race to cure B
by Larry Buhl
In 2013, a revolution happened: A drug regimen was developed that could...
Dos & Dont’s
Hep C Is Manageable—If You Know the Ins and Outs
by Larry Buhl
You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...
Hep Community: We Need More Federal Dollars
Money Talks
The hepatitis community wants more federal dollars; hep a cases rising fast
by Larry Buhl
Here’s the good news on federal funding for hepatitis research...
Care Costs
LifeGuide
New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge
by Larry Buhl
This column has covered several antiviral meds in...
HCV Under the Radar
It’s desk-clearing time for 2015 and time to visit some under-reported hepatitis C-related news. Hep C has been in the news quite a bit...
African Americans & HCV
"Race" Matters
Researchers study disparities when it comes to African Americans & HCV
by Larry Buhl
A growing number of clinicians and researchers want the African-American community...
Is Mass HCV Screening the Best Approach?
LifeGuide
Calling All Boomers
New analysis questions the need for mass HCV screening
by Larry Buhl
In 2012, the U.S. Centers for Disease Control and Prevention (CDC) recommended...
Do One Thing
With new, game-changing hepatitis C meds available or in the pipeline, an emerging issue is how to find at-risk patients, get them screened and...
LATEST POSTS
Ron B: Cover Story
“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...
